Organogenesis Holdings Inc. ORGO Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.72M+117% | $37.03M+4,201% | $1.01M— | -$8.23M— | -$15.88M— | ||
| $16M+14.3% | $15.27M+12.1% | $14.82M+14.1% | $14.36M+20.1% | $14M+29.3% | ||
| $13.57M+17.6% | $13.3M+25.7% | $11.87M+18.0% | $11.51M+18.0% | $11.54M+21.6% | ||
| -$4.61M— | $9.5M— | -$8.96M— | -$7.32M— | —— | ||
| —— | -$188K+83.5% | -$769K-33.7% | -$750K-24.2% | -$812K-56.5% | ||
| $16.97M+21.2% | $115.8M+233% | $73.13M+292% | $22.44M+45.1% | $14M+128% | ||
| $18.85M— | $18.85M— | $16.35M— | $20.09M— | —— | ||
| -$35K— | -$528K— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $8.19M+145% | $3.32M-2.4% | $3.36M-11.6% | $3.35M-20.1% | $3.34M-27.1% | ||
| $8.83M+8.5% | $8.34M-0.1% | $8.16M-3.9% | $8.06M-5.8% | $8.14M-2.5% | ||
| —— | —— | —— | -$33.18M-251% | $4.44M-82.8% | ||
| $13.67M+19.5% | $14.15M+41.1% | $12.86M+28.7% | $13.19M-1.6% | $11.44M-39.9% | ||
| -$13.67M-19.5% | -$14.15M-41.1% | -$12.86M-28.7% | -$13.19M+1.6% | -$11.44M+39.9% | ||
| —— | —— | —— | —— | —— | ||
| —— | $157K-87.4% | $1.22M+562% | $1.09M+507% | $1.09M+507% | ||
| $10.73M+872% | $1.17M+8.3% | $1.15M-2.5% | $1.13M+21.1% | $1.1M+47.8% | ||
| $3.14M+69.5% | $1.89M+60.3% | $1.8M+53.3% | $1.8M+53.0% | $1.85M+60.3% | ||
| —— | —— | —— | —— | —— | ||
| -$35.52M-226% | -$17.36M-163% | $21.1M+371% | $29.63M+492% | $28.19M+510% | ||
| —— | —— | -$30.55M— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $5.35M-23.2% | $5.56M+0.6% | $5.96M+23.5% | $7.08M+139% | ||
| -$18.63M-98.1% | -$15.35M-87.0% | -$10.29M-26.8% | -$9.83M-29.7% | -$9.4M-22.3% | ||
| $8.19M+145% | $3.32M-2.4% | $3.36M-11.6% | $3.35M-20.1% | $3.34M-27.1% | ||
| —— | —— | —— | —— | —— | ||
| -$1.11M— | $10.38M— | $1.34M— | —— | —— | ||
| $8.85M-36.3% | $8.49M-39.6% | $11.12M-2.6% | $12.31M+21.0% | $13.9M+63.3% | ||
| —— | —— | —— | —— | —— | ||
| $397K+10.9% | $375K-4.8% | $289K-31.0% | $324K-23.0% | $358K-15.8% | ||
| $8.83M+8.5% | $8.34M-0.1% | $8.16M-3.9% | $8.06M-5.8% | $8.14M-2.5% | ||
| $3.38M-12.0% | $8.21M+109% | $5.62M— | $5.02M— | $3.84M— | ||
| —— | $11.18M— | —— | —— | —— | ||
| $18.17M— | $14.46M— | —— | —— | —— | ||
| $10.73M+872% | $1.17M+8.3% | $1.15M-2.5% | $1.13M+21.1% | $1.1M+47.8% | ||
| —— | —— | —— | —— | —— | ||
| $11.63M+184% | $11.37M+532% | $8.88M+559% | $6.46M+618% | $4.1M+811% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $2.69M— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $26.98M+428% | $6.3M+226% | $6.11M+151% | $6.05M+21.4% | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Organogenesis Holdings Inc. generate?
- Organogenesis Holdings Inc. (ORGO) generated -$20.7M in operating cash flow over the trailing twelve months.
- What is Organogenesis Holdings Inc.'s free cash flow?
- After $13.7M of capital expenditures, Organogenesis Holdings Inc.'s free cash flow was -$34.5M over the trailing twelve months, down 67.6% year over year.
- Where does Organogenesis Holdings Inc.'s cash flow data come from?
- Every line is extracted from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
